175 related articles for article (PubMed ID: 35708081)
21. Toxicology and pharmacology of selenium: emphasis on synthetic organoselenium compounds.
Nogueira CW; Rocha JB
Arch Toxicol; 2011 Nov; 85(11):1313-59. PubMed ID: 21720966
[TBL] [Abstract][Full Text] [Related]
22. Organoselenium compounds from purines: Synthesis of 6-arylselanylpurines with antioxidant and anticholinesterase activities and memory improvement effect.
Duarte LFB; Oliveira RL; Rodrigues KC; Voss GT; Godoi B; Schumacher RF; Perin G; Wilhelm EA; Luchese C; Alves D
Bioorg Med Chem; 2017 Dec; 25(24):6718-6723. PubMed ID: 29157728
[TBL] [Abstract][Full Text] [Related]
23. Horseradish peroxidase inhibition and antioxidant activity of ebselen and related organoselenium compounds.
Mishra B; Priyadarsini KI; Mohan H; Mugesh G
Bioorg Med Chem Lett; 2006 Oct; 16(20):5334-8. PubMed ID: 16919452
[TBL] [Abstract][Full Text] [Related]
24. Ebselen and Analogues: Pharmacological Properties and Synthetic Strategies for Their Preparation.
Santi C; Scimmi C; Sancineto L
Molecules; 2021 Jul; 26(14):. PubMed ID: 34299505
[TBL] [Abstract][Full Text] [Related]
25. New glutathione peroxidase mimetics-Insights into antioxidant and cytotoxic activity.
Pacuła AJ; Kaczor KB; Wojtowicz A; Antosiewicz J; Janecka A; Długosz A; Janecki T; Ścianowski J
Bioorg Med Chem; 2017 Jan; 25(1):126-131. PubMed ID: 28029457
[TBL] [Abstract][Full Text] [Related]
26. The investigation of the antioxidative properties of the novel synthetic organoselenium compounds in some rat tissues.
Selamoglu Talas Z; Ozdemir I; Yilmaz I; Gok Y; Orun I
Exp Biol Med (Maywood); 2008 May; 233(5):575-9. PubMed ID: 18375834
[TBL] [Abstract][Full Text] [Related]
27. The effects of synthetic organoselenium compounds on nitric oxide in DMBA-induced rat liver.
Talas ZS; Bayraktar N; Ozdemir I; Gok Y; Yilmaz I
J Environ Biol; 2009 Jul; 30(4):591-3. PubMed ID: 20120501
[TBL] [Abstract][Full Text] [Related]
28. Highly Efficient Glutathione Peroxidase and Peroxiredoxin Mimetics Protect Mammalian Cells against Oxidative Damage.
Bhowmick D; Srivastava S; D'Silva P; Mugesh G
Angew Chem Int Ed Engl; 2015 Jul; 54(29):8449-53. PubMed ID: 26032473
[TBL] [Abstract][Full Text] [Related]
29. Development and Therapeutic Potential of Selenazo Compounds.
Ruberte AC; Sanmartin C; Aydillo C; Sharma AK; Plano D
J Med Chem; 2020 Feb; 63(4):1473-1489. PubMed ID: 31638805
[TBL] [Abstract][Full Text] [Related]
30. Glutathione peroxidase (GPx)-like antioxidant activity of the organoselenium drug ebselen: unexpected complications with thiol exchange reactions.
Sarma BK; Mugesh G
J Am Chem Soc; 2005 Aug; 127(32):11477-85. PubMed ID: 16089478
[TBL] [Abstract][Full Text] [Related]
31. Mechanisms of ebselen as a therapeutic and its pharmacology applications.
Wang J; Wang P; Dong C; Zhao Y; Zhou J; Yuan C; Zou L
Future Med Chem; 2020 Dec; 12(23):2141-2160. PubMed ID: 33225732
[TBL] [Abstract][Full Text] [Related]
32. Synthesis and evaluation of dihydropyrimidinone-derived selenoesters as multi-targeted directed compounds against Alzheimer's disease.
Barbosa FAR; Canto RFS; Saba S; Rafique J; Braga AL
Bioorg Med Chem; 2016 Nov; 24(22):5762-5770. PubMed ID: 27681239
[TBL] [Abstract][Full Text] [Related]
33. Reaction of low-molecular-mass organoselenium compounds (and their sulphur analogues) with inflammation-associated oxidants.
Carroll L; Davies MJ; Pattison DI
Free Radic Res; 2015 Jun; 49(6):750-67. PubMed ID: 25854915
[TBL] [Abstract][Full Text] [Related]
34. Organoselenium compounds as mimics of selenoproteins and thiol modifier agents.
Barbosa NV; Nogueira CW; Nogara PA; de Bem AF; Aschner M; Rocha JBT
Metallomics; 2017 Dec; 9(12):1703-1734. PubMed ID: 29168872
[TBL] [Abstract][Full Text] [Related]
35. 2,2'-dipyridyl diselenide is a better antioxidant than other disubstituted diaryl diselenides.
Luchese C; Brandão R; Acker CI; Nogueira CW
Mol Cell Biochem; 2012 Aug; 367(1-2):153-63. PubMed ID: 22544521
[TBL] [Abstract][Full Text] [Related]
36. Ebselen and diphenyl diselenide against fungal pathogens: A systematic review.
Benelli JL; Poester VR; Munhoz LS; Melo AM; Trápaga MR; Stevens DA; Xavier MO
Med Mycol; 2021 May; 59(5):409-421. PubMed ID: 33421963
[TBL] [Abstract][Full Text] [Related]
37. Synthesis and biological evaluation of new nitrogen-containing diselenides.
Nascimento V; Ferreira NL; Canto RF; Schott KL; Waczuk EP; Sancineto L; Santi C; Rocha JB; Braga AL
Eur J Med Chem; 2014 Nov; 87():131-9. PubMed ID: 25244678
[TBL] [Abstract][Full Text] [Related]
38. Ebselen ameliorates β-amyloid pathology, tau pathology, and cognitive impairment in triple-transgenic Alzheimer's disease mice.
Xie Y; Tan Y; Zheng Y; Du X; Liu Q
J Biol Inorg Chem; 2017 Aug; 22(6):851-865. PubMed ID: 28502066
[TBL] [Abstract][Full Text] [Related]
39. Synthesis, structure, and glutathione peroxidase-like activity of amino acid containing ebselen analogues and diaryl diselenides.
Selvakumar K; Shah P; Singh HB; Butcher RJ
Chemistry; 2011 Nov; 17(45):12741-55. PubMed ID: 21956838
[TBL] [Abstract][Full Text] [Related]
40. Synthesis and evaluation of multi-target-directed ligands with BACE-1 inhibitory and Nrf2 agonist activities as potential agents against Alzheimer's disease.
Qu L; Ji L; Wang C; Luo H; Li S; Peng W; Yin F; Lu D; Liu X; Kong L; Wang X
Eur J Med Chem; 2021 Jul; 219():113441. PubMed ID: 33862517
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
